Mycobacterium tuberculosis Dihydrofolate Reductase Reveals Two Conformational States and a Possible Low Affinity Mechanism to Antifolate Drugs
- 1 January 2014
- Vol. 22 (1) , 94-103
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Two Parallel Pathways in the Kinetic Sequence of the Dihydrofolate Reductase from Mycobacterium tuberculosisBiochemistry, 2011
- iMOSFLM: a new graphical interface for diffraction-image processing withMOSFLMActa Crystallographica Section D Structural Biology, 2011
- Kinetic and Chemical Mechanism of the Dihydrofolate Reductase from Mycobacterium tuberculosisBiochemistry, 2010
- PHENIX: a comprehensive Python-based system for macromolecular structure solutionActa Crystallographica Section D Structural Biology, 2010
- Cancer research: from folate antagonism to molecular targetsBest Practice & Research Clinical Haematology, 2009
- Mycobacterium tuberculosis dihydrofolate reductase is a target for isoniazidNature Structural & Molecular Biology, 2006
- The folic acid biosynthesis pathway in bacteria: evaluation of potential for antibacterial drug discoveryBioEssays, 2002
- A Metabolic Node in Action: Chorismate-Utilizing Enzymes in MicroorganismsCritical Reviews in Microbiology, 2001
- Crystal structure of unliganded Escherichia coli dihydrofolate reductase. Ligand-induced conformational changes and cooperativity in bindingBiochemistry, 1991
- Multinuclear NMR characterization of two coexisting conformational states of the Lactobacillus casei dihydrofolate reductase-trimethoprim-NADP complexBiochemistry, 1984